Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA: 600196)
China
· Delayed Price · Currency is CNY
24.60
+0.44 (1.82%)
Jan 6, 2025, 1:22 PM CST
Shanghai Fosun Pharmaceutical (Group) Employees
Shanghai Fosun Pharmaceutical (Group) had 40,370 employees as of December 31, 2023. The number of employees increased by 1,971 or 5.13% compared to the previous year.
Employees
40,370
Change (1Y)
1,971
Growth (1Y)
5.13%
Revenue / Employee
1.03M CNY
Profits / Employee
52.36K CNY
Market Cap
59.19B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 18,044 |
Jiangsu Hengrui Medicine | 19,611 |
WuXi AppTec | 41,116 |
Zhangzhou Pientzehuang Pharmaceutical., | 2,789 |
Aier Eye Hospital Group | 36,718 |
Shanghai United Imaging Healthcare | 7,440 |
Yunnan Baiyao Group Co.,Ltd | 8,834 |
Beijing Wantai Biological Pharmacy Enterprise | 3,843 |
Shanghai Fosun Pharmaceutical (Group) News
- 1 year ago - Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse - Reuters
- 2 years ago - Fosun Pharma Shares Gain After Tie-Up With New Covid Drug Supplier Genuine Biotech - Forbes
- 3 years ago - Week In Review: Nuance In-Licenses RSV Vaccine In $225 Million Deal - Seeking Alpha
- 3 years ago - Pandemic Accelerates China's Drive Into mRNA Treatments - Seeking Alpha
- 3 years ago - Week In Review: Genscript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse - Seeking Alpha
- 3 years ago - Week In Review: CANbridge Licenses LogicBio's Adeno-Associated Virus For Gene Therapies In $591 Million Deal - Seeking Alpha
- 4 years ago - Fosun Pharma shares tumble more than 5% as Hong Kong suspends BioNTech Covid vaccinations - CNBC